Your AI-Trained Oncology Knowledge Connection!

Natalia Bolotova

Articles by Natalia Bolotova

18 Tolerability of First-Line Treatment With Ribociclib for Metastatic Breast Cancer Using 2 Large US Data Sources

ByRadhika Appaya,Sarah Sammons, MD,Priyanka Sharma, MD,Yara Abdou,VK Gadi, MD, PhD,Taavy A. Miller,Spencer S. Langerman,Dominick Latremouille-Viau,Annie Guerin,Carmine Rossi,Emily McGovern,Gary Sopher,Vamsi Bollu,Natalia Bolotova,Şerban R. Iorga,Liz Santarsiero,Susan Dent, MD

June 30th 2025

Latest Updated Articles

Trending on CancerNetwork

T-DXd Improves Invasive DFS vs T-DM1 in HER2+ Early Breast Cancer Subgroup

Proton Beam Therapy and IMRT Confer Similar AEs and QOL in Oropharyngeal Cancer

Certepetide/FOLFIRINOX Displays Encouraging Preliminary Feasibility in PDAC

Introductions and an Overview of Multiple Myeloma Treatments

Subcutaneous Daratumumab Provides “Win-Win” in NDMM Maintenance

© 2025 MJH Life Sciences^®

All rights reserved.